CMMB vs PCG · $22.2M cap vs P/E 13, rev $12.78B
Chemomab Therapeutics Ltd DRC (CMMB) versus PG&E Corp (PCG) — a side-by-side from cached financials, not a winner call.
Chemomab Therapeutics Ltd DRC (CMMB) is a biotechnology company listed on US.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
CMMB does not have a complete income-statement cache yet.
Latest reported PCG revenue for 2026-06-30 was $12.78B. Net income was $1.65B. Revenue was up 85.8% from 2026-03-31 to 2026-06-30. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
CMMB currently screens at market cap $22.2M. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
Not investment advice. Open the CMMB and PCG stock pages for the full models.
Not investment advice.